4-[(1E)-3-(4-Methoxyphenyl)-3-oxoprop-1-en-1-yl]phenyl cyclohexanecarboxylate

Catalog No. :
ACTORH582
CAS No. :
331460-83-4
Molecular Formula :
C23H24O4
Molecular Weight :
364.44

IUPAC Name:(E)-4-(3-(4-methoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl cyclohexanecarboxylate

4-[(1E)-3-(4-Methoxyphenyl)-3-oxoprop-1-en-1-yl]phenyl cyclohexanecarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[(1E)-3-(4-Methoxyphenyl)-3-oxoprop-1-en-1-yl]phenyl cyclohexanecarboxylate
IUPAC Name(E)-4-(3-(4-methoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl cyclohexanecarboxylate
MDL No.MFCD00169561
Molecular FormulaC23H24O4
Molecular Weight364.44
SMILESO=C(C1CCCCC1)OC2=CC=C(/C=C/C(C3=CC=C(OC)C=C3)=O)C=C2
InChI KeyMPRVZMSZKXHNED-CXUHLZMHSA-N
Synonym4-[3-(4-METHOXYPHENYL)-3-OXO-1-PROPENYL]PHENYL CYCLOHEXANECARBOXYLATE;4-[(1E)-3-(4-methoxyphenyl)-3-oxoprop-1-en-1-yl]phenyl cyclohexanecarboxylate;Cyclohexanecarboxylic acid, 4-[3-(4-methoxyphenyl)-3-oxo-1-propen-1-yl]phenyl ester;(E)-4-(3-(4-methoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl cyclohexanecarboxylate;CYCLOHEXANECARBOXYLIC ACID 4-(3-(4-METHOXY-PHENYL)-3-OXO-PROPENYL)-PHENYL ESTER
CAS No.331460-83-4

Synthetic Route by SureRoute

1. ACTORH582 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTORH582 route product structure diagram
    ACTORH582331460-83-4
Inquiry

2. ACTORH582 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTORH582 route product structure diagram
    ACTORH582331460-83-4
Inquiry

Comments (0)